Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional

Background: In Chile, in the next 20 years there will be an average number of 537,100 women of childbearing age with type 2 diabetes (T2DM). Half of these women, not knowing their diagnosis of diabetes will become pregnant with elevated glycosylated hemoglobin levels, increasing to 25% the risk of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Olmos Coelho,Pablo, Borzone Tassara,Gisella, Poblete Lizana,Andrés, Oyarzún Ebensperger,Enrique
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2020
Materias:	Congenital Abnormalities Diabetes Mellitus, Type 2 Markov Chains Prevalence Prevention & Control
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000801171
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872020000801171
record_format	dspace
spelling	oai:scielo:S0034-988720200008011712020-12-26Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacionalOlmos Coelho,PabloBorzone Tassara,GisellaPoblete Lizana,AndrésOyarzún Ebensperger,Enrique Congenital Abnormalities Diabetes Mellitus, Type 2 Markov Chains Prevalence Prevention & Control Background: In Chile, in the next 20 years there will be an average number of 537,100 women of childbearing age with type 2 diabetes (T2DM). Half of these women, not knowing their diagnosis of diabetes will become pregnant with elevated glycosylated hemoglobin levels, increasing to 25% the risk of having offspring with congenital malformations. Aim: To calculate the cost-effectiveness of a diabetes detection strategy in women of childbearing age for the prevention of congenital malformations in the period 2020-2039. Material and Methods: The Markov stochastic model was used in two scenarios, namely A: No intervention and B: Intervention, detecting T2DM in Chilean women aged 15-49 years. We calculated the years of life lost due to premature death (YLL), years of life lost adjusted for disability (DALY) and total costs using American dollars (US$) of 2017, with a discount rate of 5%. Results: In scenario A: 63,330 children with malformations would be born, YLLs and DALYs would be 800,750 and 1,544,775 respectively, and US$ 10,194,298,011 would be expended. In scenario B, these figures would be reduced in approximately 70% to 19,025 children born with malformations, YLLS and DALYs would be 40,539 and 464,033 respectively and US$ 3,354,321,968 would be expended. The costs of prevention would be US$ 6,590.94/malformation avoided, US$ 521.33/YLL avoided, and US$ 270.24/DALY avoided. Conclusions: In the context of an increasing prevalence of diabetes in women of childbearing age, our results suggest that the early detection of diabetes in Chilean women between 15 and 49 years of age, should be cost-effective to avoid an increase in congenital malformations for the next 20 years.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.148 n.8 20202020-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000801171es10.4067/S0034-98872020000801171
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Congenital Abnormalities Diabetes Mellitus, Type 2 Markov Chains Prevalence Prevention & Control
spellingShingle	Congenital Abnormalities Diabetes Mellitus, Type 2 Markov Chains Prevalence Prevention & Control Olmos Coelho,Pablo Borzone Tassara,Gisella Poblete Lizana,Andrés Oyarzún Ebensperger,Enrique Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
description	Background: In Chile, in the next 20 years there will be an average number of 537,100 women of childbearing age with type 2 diabetes (T2DM). Half of these women, not knowing their diagnosis of diabetes will become pregnant with elevated glycosylated hemoglobin levels, increasing to 25% the risk of having offspring with congenital malformations. Aim: To calculate the cost-effectiveness of a diabetes detection strategy in women of childbearing age for the prevention of congenital malformations in the period 2020-2039. Material and Methods: The Markov stochastic model was used in two scenarios, namely A: No intervention and B: Intervention, detecting T2DM in Chilean women aged 15-49 years. We calculated the years of life lost due to premature death (YLL), years of life lost adjusted for disability (DALY) and total costs using American dollars (US$) of 2017, with a discount rate of 5%. Results: In scenario A: 63,330 children with malformations would be born, YLLs and DALYs would be 800,750 and 1,544,775 respectively, and US$ 10,194,298,011 would be expended. In scenario B, these figures would be reduced in approximately 70% to 19,025 children born with malformations, YLLS and DALYs would be 40,539 and 464,033 respectively and US$ 3,354,321,968 would be expended. The costs of prevention would be US$ 6,590.94/malformation avoided, US$ 521.33/YLL avoided, and US$ 270.24/DALY avoided. Conclusions: In the context of an increasing prevalence of diabetes in women of childbearing age, our results suggest that the early detection of diabetes in Chilean women between 15 and 49 years of age, should be cost-effective to avoid an increase in congenital malformations for the next 20 years.
author	Olmos Coelho,Pablo Borzone Tassara,Gisella Poblete Lizana,Andrés Oyarzún Ebensperger,Enrique
author_facet	Olmos Coelho,Pablo Borzone Tassara,Gisella Poblete Lizana,Andrés Oyarzún Ebensperger,Enrique
author_sort	Olmos Coelho,Pablo
title	Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
title_short	Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
title_full	Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
title_fullStr	Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
title_full_unstemmed	Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
title_sort	continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional
publisher	Sociedad Médica de Santiago
publishDate	2020
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000801171
work_keys_str_mv	AT olmoscoelhopablo continuoascensodelaprevalenciadediabetesmellitusenmujereschilenasenedadfertilproyeccion20202039demalformacionescongenitaspordiabetespregestacional AT borzonetassaragisella continuoascensodelaprevalenciadediabetesmellitusenmujereschilenasenedadfertilproyeccion20202039demalformacionescongenitaspordiabetespregestacional AT pobletelizanaandres continuoascensodelaprevalenciadediabetesmellitusenmujereschilenasenedadfertilproyeccion20202039demalformacionescongenitaspordiabetespregestacional AT oyarzunebenspergerenrique continuoascensodelaprevalenciadediabetesmellitusenmujereschilenasenedadfertilproyeccion20202039demalformacionescongenitaspordiabetespregestacional
_version_	1718437146442858496

Continuo ascenso de la prevalencia de diabetes mellitus en mujeres chilenas en edad fértil: proyección 2020-2039 de malformaciones congénitas por diabetes pregestacional

Ejemplares similares